Marit M. Melssen

Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts

Anthony B. Rodriguez, J. David Peske, Amber N. Woods et al. · Cell Reports · 2021 · 220 citations · Full text

A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients

Marit M. Melssen, Gina R. Petroni, Kimberly A. Chianese‐Bullock et al. · Journal for ImmunoTherapy of Cancer · 2019 · 95 citations · Full text

An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes

Abhinav Jaiswal, Akanksha Verma, Ruth Dannenfelser et al. · Cancer Cell · 2022 · 58 citations · Full text

Cancer Immunosurveillance, Melanoma, Immunology +6

Endothelial VEGFR2-PLCγ signaling regulates vascular permeability and antitumor immunity through eNOS/Src

Elin Sjöberg, Marit M. Melssen, Mark Richards et al. · Journal of Clinical Investigation · 2023 · 41 citations · Full text

Endothelial Phospholipase Cγ, Immunology, Renal Inflammation +23

Incomplete Freund’s adjuvant reduces arginase and enhances Th1 dominance, TLR signaling and CD40 ligand expression in the vaccine site microenvironment

Karlyn Pollack, Max O. Meneveau, Marit M. Melssen et al. · Journal for ImmunoTherapy of Cancer · 2020 · 32 citations · Full text